Quick Reference Guide
... 2) Using this model in a patient on therapy only reflects the theoretical risk of a hypothetical patient who is treatment naïve and does not reflect the risk reduction associated with therapy. 3) Femoral neck T-score should be derived from NHANES III Caucasian women reference database. 4) Individual ...
... 2) Using this model in a patient on therapy only reflects the theoretical risk of a hypothetical patient who is treatment naïve and does not reflect the risk reduction associated with therapy. 3) Femoral neck T-score should be derived from NHANES III Caucasian women reference database. 4) Individual ...
Connective Tissue
... estrogen antagonist in breast tissue, agonist in bone, agonist in uterine tissue binds to ER-alpha receptor decreased risk of breast cancer decreased LDL and total cholesterol side effects: increased risk of thromboembolism Bisphosphonates – Pryrophosphate homologs side effects: heartbur ...
... estrogen antagonist in breast tissue, agonist in bone, agonist in uterine tissue binds to ER-alpha receptor decreased risk of breast cancer decreased LDL and total cholesterol side effects: increased risk of thromboembolism Bisphosphonates – Pryrophosphate homologs side effects: heartbur ...
Gait, Balance and Osteoporosis Treatment in Seniors
... – Osteoporosis= thinner bones, higher risk ...
... – Osteoporosis= thinner bones, higher risk ...
Effect Of Androgens On Bone Mineral Density In Saudi
... male Saudi Arabs above the age of 50 years. Methods: Male Saudi patients over the age of 50 years, attending the outpatient clinics between May 2005 and January 2006 of King Fahd Hospital of the University, Al-Kbobar, Kingdom of Saudi Arabia, comprised the study subjects. Patient's body mass index w ...
... male Saudi Arabs above the age of 50 years. Methods: Male Saudi patients over the age of 50 years, attending the outpatient clinics between May 2005 and January 2006 of King Fahd Hospital of the University, Al-Kbobar, Kingdom of Saudi Arabia, comprised the study subjects. Patient's body mass index w ...
Color Atlas of Pharmacology - ReadingSample - Beck-Shop
... result is a reduction in bone resorption and a decreased risk of bone fractures. Raloxifene exerts an estrogen-like effect on bone, while acting as an estrogen antagonist in the uterus and breast tissue (p. 254). In terms of fracture prophylaxis, its effectiveness appears inferior to that of bisphos ...
... result is a reduction in bone resorption and a decreased risk of bone fractures. Raloxifene exerts an estrogen-like effect on bone, while acting as an estrogen antagonist in the uterus and breast tissue (p. 254). In terms of fracture prophylaxis, its effectiveness appears inferior to that of bisphos ...
OSTEOPOROSIS, WHAT YOU NEED TO KNOW
... fractures. Other forms of drug therapy that can cause bone loss include long-term treatment with certain antiseizure drugs, such as phenytoin and barbiturates; gonadotropin-releasing hormone (GnRH) analogs used to treat endometriosis; excessive use of aluminum-containing antacids; certain cancer tre ...
... fractures. Other forms of drug therapy that can cause bone loss include long-term treatment with certain antiseizure drugs, such as phenytoin and barbiturates; gonadotropin-releasing hormone (GnRH) analogs used to treat endometriosis; excessive use of aluminum-containing antacids; certain cancer tre ...
Bone Mineral Density Testing
... Women who are considering therapy in which BMD will affect that decision Women who have been on hormone replacement therapy (HRT) for prolonged periods Men who experience fractures after minimal trauma People with evidence of osteopenia on radiographs or a disease known to place them at risk for ost ...
... Women who are considering therapy in which BMD will affect that decision Women who have been on hormone replacement therapy (HRT) for prolonged periods Men who experience fractures after minimal trauma People with evidence of osteopenia on radiographs or a disease known to place them at risk for ost ...
6 Important Breakthroughs in Osteoporosis Treatment
... Currently, clinical trials around the world are using a medication to inhibit cathepsin K, an enzyme that digests bone. “They’re looking to see if it protects against fractures,” says Dr. Cheung. “We’re all waiting for the results.” Researchers at Stony Brook University in New York are working with ...
... Currently, clinical trials around the world are using a medication to inhibit cathepsin K, an enzyme that digests bone. “They’re looking to see if it protects against fractures,” says Dr. Cheung. “We’re all waiting for the results.” Researchers at Stony Brook University in New York are working with ...
BoneLossQ11
... While family history is a risk factor that cannot be controlled by patient, there are preventive measures that can help postpone or prevent early onset of osteoporosis. Adequate calcium and vitamin D is an important factor in reducing risk of osteoporosis. If patient already has osteoporosis, gettin ...
... While family history is a risk factor that cannot be controlled by patient, there are preventive measures that can help postpone or prevent early onset of osteoporosis. Adequate calcium and vitamin D is an important factor in reducing risk of osteoporosis. If patient already has osteoporosis, gettin ...
Notes/Initials 11. I have a family history of osteoporosis Yes
... While family history is a risk factor that cannot be controlled by patient, there are preventive measures that can help postpone or prevent early onset of osteoporosis. Adequate calcium and vitamin D is an important factor in reducing risk of osteoporosis. If patient already has osteoporosis, gettin ...
... While family history is a risk factor that cannot be controlled by patient, there are preventive measures that can help postpone or prevent early onset of osteoporosis. Adequate calcium and vitamin D is an important factor in reducing risk of osteoporosis. If patient already has osteoporosis, gettin ...
No Slide Title
... • CBC, TFT’s • Chem Profile to include: – Albumin (Nutritional?) – Renal/Liver function – Calcium (Elevated in Hyperparathyroid) – Phosphate (Low in Osteomalacia) – Alk Phos (Elevated in Osteomalacia) ...
... • CBC, TFT’s • Chem Profile to include: – Albumin (Nutritional?) – Renal/Liver function – Calcium (Elevated in Hyperparathyroid) – Phosphate (Low in Osteomalacia) – Alk Phos (Elevated in Osteomalacia) ...
osteoporosis
... • Female sex • Advanced age • Race/ethnicity • History of previous low trauma (fragility) fracture • Osteoporotic fracture in first-degree relative • Low body weight or body mass index • Premature menopause (before age 45) • Secondary osteoporosis (especially rheumatoid arthritis) • Past or present ...
... • Female sex • Advanced age • Race/ethnicity • History of previous low trauma (fragility) fracture • Osteoporotic fracture in first-degree relative • Low body weight or body mass index • Premature menopause (before age 45) • Secondary osteoporosis (especially rheumatoid arthritis) • Past or present ...
Predictors of reproductive and metabolic phenotypes in
... preventive medicine visit History significant for type 2 diabetes-well controlled on metformin No personal/family history of fracture No history of malabsorption or thyroid disease Menopause 15 years ago, no hormone replacement therapy Denies alcohol/smoking Two dairy servings/day, calcium carbonate ...
... preventive medicine visit History significant for type 2 diabetes-well controlled on metformin No personal/family history of fracture No history of malabsorption or thyroid disease Menopause 15 years ago, no hormone replacement therapy Denies alcohol/smoking Two dairy servings/day, calcium carbonate ...
TO ALL STAFF
... Risk factors (Females) Low Calcium intake Regular Steroid use Lack of exercise Smoking Excessive Dieting (anorexia) Family history of Osteoporosis Overactive Thyroid Gland Hysterectomy with ovaries removed Previous Fracture (from a low impact fall) Early Menopause or Post-menopausal and not on HRT ...
... Risk factors (Females) Low Calcium intake Regular Steroid use Lack of exercise Smoking Excessive Dieting (anorexia) Family history of Osteoporosis Overactive Thyroid Gland Hysterectomy with ovaries removed Previous Fracture (from a low impact fall) Early Menopause or Post-menopausal and not on HRT ...
Osteoporosis
Osteoporosis is a disease where decreased bone strength increases the risk of a broken bone. It is the most common reason for a broken bone among people who are old. Bones that commonly break include the back bones, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no symptoms. Bones may weaken to such a degree that a break may occur with minor stress or spontaneously. Chronic pain and a decreased ability to carry out normal activities may occur following a broken bone.Osteoporosis may be due to lower than normal peak bone mass and greater than normal bone loss. Bone loss increases after menopause due to lower levels of estrogen. Osteoporosis may also occur due to a number of diseases or treatments including alcoholism, anorexia, hyperthyroidism, surgical removal of the ovaries, and kidney disease. Certain medications increase the rate of bone loss including some antiseizure medications, chemotherapy, proton pump inhibitors, selective serotonin reuptake inhibitors and steroids. Not enough exercise and smoking are also risk factors. Osteoporosis is defined as a bone density of 2.5 standard deviations below that of a young adult. This is typically measured by dual-energy X-ray absorptiometry at the hip.Prevention of osteoporosis includes a proper diet during childhood and efforts to avoid medications that cause the condition. Efforts to prevent broken bones in those with osteoporosis include a good diet, exercise, and fall prevention. Lifestyle changes such as stopping smoking and not drinking alcohol may help. Medication of the bisphosphonate type are useful in those with previous broken bones due to osteoporosis. In those with osteoporosis but no previous broken bones they are less effective. A number of other medications may also be useful.Osteoporosis becomes more common with age. About 15% of white people in their 50s and 70% of those over 80 are affected. It is more common in women than men. In the developed world, depending on the method of diagnosis, 2% to 8% of males and 9% to 38% of females are affected. Rates of disease in the developing world are unclear. About 22 million women and 5.5 million men in the European Union had osteoporosis in 2010. In the United States in 2010 about eight million women and one to two million men had osteoporosis. White and Asian people are at greater risk. The word osteoporosis is from the Greek terms for ""porous bones"".